These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 35263323)

  • 1. The IgA in milk induced by SARS-CoV-2 infection is comprised of mainly secretory antibody that is neutralizing and highly durable over time.
    Fox A; Marino J; Amanat F; Oguntuyo KY; Hahn-Holbrook J; Lee B; Zolla-Pazner S; Powell RL
    PLoS One; 2022; 17(3):e0249723. PubMed ID: 35263323
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Secretory IgA Response in Human Milk Against the SARS-CoV-2 Spike Is Highly Durable and Neutralizing for At Least 1 Year of Lactation Postinfection.
    Yang X; Fox A; DeCarlo C; Pineda N; Powell RLR
    Breastfeed Med; 2023 Aug; 18(8):602-611. PubMed ID: 37615565
    [No Abstract]   [Full Text] [Related]  

  • 3. Immune Response of Neonates Born to Mothers Infected With SARS-CoV-2.
    Conti MG; Terreri S; Piano Mortari E; Albano C; Natale F; Boscarino G; Zacco G; Palomba P; Cascioli S; Corrente F; Capponi C; Mirabella M; Salinas AF; Marciano A; De Luca F; Pangallo I; Quaranta C; Alteri C; Russo C; Galoppi P; Brunelli R; Perno CF; Terrin G; Carsetti R
    JAMA Netw Open; 2021 Nov; 4(11):e2132563. PubMed ID: 34730817
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical validation of the Siemens quantitative SARS-CoV-2 spike IgG assay (sCOVG) reveals improved sensitivity and a good correlation with virus neutralization titers.
    Irsara C; Egger AE; Prokop W; Nairz M; Loacker L; Sahanic S; Pizzini A; Sonnweber T; Holzer B; Mayer W; Schennach H; Loeffler-Ragg J; Bellmann-Weiler R; Hartmann B; Tancevski I; Weiss G; Binder CJ; Anliker M; Griesmacher A; Hoermann G
    Clin Chem Lab Med; 2021 Jul; 59(8):1453-1462. PubMed ID: 33837679
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of Severe Acute Respiratory Syndrome Coronavirus 2-Specific Antibodies' Binding Capacity Between Human Milk and Serum from Coronavirus Disease 2019-Recovered Women.
    Demers-Mathieu V; DaPra C; Medo E
    Breastfeed Med; 2021 May; 16(5):393-401. PubMed ID: 33835835
    [No Abstract]   [Full Text] [Related]  

  • 6. Anti-SARS-CoV-2 IgG and IgA antibodies in COVID-19 convalescent plasma do not enhance viral infection.
    Clark NM; Janaka SK; Hartman W; Stramer S; Goodhue E; Weiss J; Evans DT; Connor JP
    PLoS One; 2022; 17(3):e0257930. PubMed ID: 35259162
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Human Milk Antibodies Against S1 and S2 Subunits from SARS-CoV-2, HCoV-OC43, and HCoV-229E in Mothers with A Confirmed COVID-19 PCR, Viral SYMPTOMS, and Unexposed Mothers.
    Demers-Mathieu V; DaPra C; Mathijssen G; A Sela D; M Jarvinen K; Seppo A; Fels S; Medo E
    Int J Mol Sci; 2021 Feb; 22(4):. PubMed ID: 33572480
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Human Milk from Previously COVID-19-Infected Mothers: The Effect of Pasteurization on Specific Antibodies and Neutralization Capacity.
    van Keulen BJ; Romijn M; Bondt A; Dingess KA; Kontopodi E; van der Straten K; den Boer MA; Burger JA; Poniman M; Bosch BJ; Brouwer PJM; de Groot CJM; Hoek M; Li W; Pajkrt D; Sanders RW; Schoonderwoerd A; Tamara S; Timmermans RAH; Vidarsson G; Stittelaar KJ; Rispens TT; Hettinga KA; van Gils MJ; Heck AJR; van Goudoever JB
    Nutrients; 2021 May; 13(5):. PubMed ID: 34068142
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Durable antibody and effector memory T cell responses in breastmilk from women with SARS-CoV-2.
    Narayanaswamy V; Pentecost BT; Telfer JC; Burnside AS; Schneider SS; Alfandari D; Baker RL; Saiju A; Nodiff S; Arcaro KF
    Front Immunol; 2022; 13():985226. PubMed ID: 36172379
    [TBL] [Abstract][Full Text] [Related]  

  • 10. SARS-CoV-2 antibodies and their neutralizing capacity against live virus in human milk after COVID-19 infection and vaccination: prospective cohort studies.
    Ismail S; Unger S; Budylowski P; Poutanen S; Yau Y; Jenkins C; Anwer S; Christie-Holmes N; Kiss A; Mazzulli T; Johnstone J; McGeer A; Whittle W; Parvez B; Gray-Owen SD; Stone D; O'Connor DL
    Am J Clin Nutr; 2024 Feb; 119(2):485-495. PubMed ID: 38309831
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The secretory IgA (sIgA) response in human milk against the SARS-CoV-2 Spike is highly durable and neutralizing for at least 1 year of lactation post-infection.
    Yang X; Fox A; DeCarlo C; Pineda N; Powell RLR
    medRxiv; 2023 May; ():. PubMed ID: 37293109
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparative Profiles of SARS-CoV-2 Spike-Specific Human Milk Antibodies Elicited by mRNA- and Adenovirus-Based COVID-19 Vaccines.
    Yang X; Fox A; DeCarlo C; Norris C; Griffin S; Wedekind S; Flanagan JM; Shenker N; Powell RL
    Breastfeed Med; 2022 Aug; 17(8):638-646. PubMed ID: 35675683
    [No Abstract]   [Full Text] [Related]  

  • 13. Sequential Analysis of Binding and Neutralizing Antibody in COVID-19 Convalescent Patients at 14 Months After SARS-CoV-2 Infection.
    Rosati M; Terpos E; Ntanasis-Stathopoulos I; Agarwal M; Bear J; Burns R; Hu X; Korompoki E; Donohue D; Venzon DJ; Dimopoulos MA; Pavlakis GN; Felber BK
    Front Immunol; 2021; 12():793953. PubMed ID: 34899762
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vivo antiviral efficacy of LCTG-002, a pooled, purified human milk secretory IgA product, against SARS-CoV-2 in a murine model of COVID-19.
    Mane V; Mehta R; Alvarez N; Sharma V; Park S; Fox A; DeCarlo C; Yang X; Perlin DS; Powell RLR
    Hum Vaccin Immunother; 2024 Dec; 20(1):2303226. PubMed ID: 38251677
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Original antigenic sin responses to Betacoronavirus spike proteins are observed in a mouse model, but are not apparent in children following SARS-CoV-2 infection.
    Lapp SA; Edara VV; Lu A; Lai L; Hussaini L; Chahroudi A; Anderson LJ; Suthar MS; Anderson EJ; Rostad CA
    PLoS One; 2021; 16(8):e0256482. PubMed ID: 34449792
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Analytical and clinical performances of a SARS-CoV-2 S-RBD IgG assay: comparison with neutralization titers.
    Padoan A; Bonfante F; Cosma C; Di Chiara C; Sciacovelli L; Pagliari M; Bortolami A; Costenaro P; Musso G; Basso D; Giaquinto C; Plebani M
    Clin Chem Lab Med; 2021 Jul; 59(8):1444-1452. PubMed ID: 33855843
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Difference in levels of SARS-CoV-2 S1 and S2 subunits- and nucleocapsid protein-reactive SIgM/IgM, IgG and SIgA/IgA antibodies in human milk.
    Demers-Mathieu V; Do DM; Mathijssen GB; Sela DA; Seppo A; Järvinen KM; Medo E
    J Perinatol; 2021 Apr; 41(4):850-859. PubMed ID: 32873904
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Detection of cross-reactive immunoglobulin A against the severe acute respiratory syndrome-coronavirus-2 spike 1 subunit in saliva.
    Tsukinoki K; Yamamoto T; Handa K; Iwamiya M; Saruta J; Ino S; Sakurai T
    PLoS One; 2021; 16(11):e0249979. PubMed ID: 34813596
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Response and Duration of Serum Anti-SARS-CoV-2 Antibodies After Inactivated Vaccination Within 160 Days.
    Xu QY; Xue JH; Xiao Y; Jia ZJ; Wu MJ; Liu YY; Li WL; Liang XM; Yang TC
    Front Immunol; 2021; 12():786554. PubMed ID: 35003104
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evolution of antibody responses up to 13 months after SARS-CoV-2 infection and risk of reinfection.
    Gallais F; Gantner P; Bruel T; Velay A; Planas D; Wendling MJ; Bayer S; Solis M; Laugel E; Reix N; Schneider A; Glady L; Panaget B; Collongues N; Partisani M; Lessinger JM; Fontanet A; Rey D; Hansmann Y; Kling-Pillitteri L; Schwartz O; De Sèze J; Meyer N; Gonzalez M; Schmidt-Mutter C; Fafi-Kremer S
    EBioMedicine; 2021 Sep; 71():103561. PubMed ID: 34455390
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.